P3.09-10 Circulating Cell-Free DNA (cfDNA) Molecular Profile of Thai NSCLC Patients Using Difference Variant Frequency of NGS

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1779
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.09-19 Matched Thai Lung Cancer Patients Tissue and cfDNA Molecular Profile by NGS

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.09-08 Tumor Heterogeneity and Molecular Profile of NSCLC in Thai Population

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-132 Comparison Molecular Profiles in NSCLC by Using Different NGS Platforms and Different Variant Frequency Cutoff

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.03-020 Unique Molecular Profile of NSCLC in Thai Population

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Circulating Cell-Free DNA

2019English

P1.09-13 Detection of Actionable Mutations in Plasma cfDNA Samples From NSCLC Patients Using a Novel Amplicon-Based Firefly NGS Assay

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA16.01 Frequency and Genomic Context of Emerging Markers for Molecular Testing in Lung Adenocarcinoma in Cell-Free DNA NGS Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Genetic Alteration and Mutation Profiling of Circulating Cell-Free Tumor DNA (cfDNA) for Diagnosis and Targeted Therapy of Gastrointestinal Stromal Tumors

Chinese Journal of Cancer
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy